This suggests that BCAT1 may be a direct transcriptional target of c-MYC and an effector through which c-MYC exerts its oncogenic influence, a relationship that has previously been demonstrated in nasopharyngeal carcinoma (51), but needs to be explored in ovarian cancers. This evidence concerns the gene BCAT1 and ovarian carcinoma.